Figure 3From: Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia Number of cases avoided with PCV13 and PPSV23 compared to no vaccination in a cohort of people over 50 years in Colombia, 2012. Back to article page